FindTrial
Sign In

The Clinical Significance of CXCL5 in Sepsis Early Warning and Prognostic Assessment

The Clinical Significance of CXCL5 in Sepsis Early Warning and Prognostic Assessment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085609
Enrollment
Unknown
Registered
2024-06-13
Start date
2023-10-16
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spesis

Interventions

sepsis group:none
healthy group:none

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients With Sepsis; Age = 18 years old; Meet the Sepsis 3.0 diagnostic criteria

Exclusion criteria

Exclusion criteria: Patients with end-stage chronic diseases, tumors, autoimmune diseases, immunodeficiency, or those undergoing prolonged immunosuppressive therapy.

Design outcomes

Primary

MeasureTime frame
CXCL5 expression levels;—

Secondary

MeasureTime frame
CRP levels;PCT levels;IL-6 levels;IL-10 levels;lactic acid level;respiratory rate;APACHE II score;—

Countries

China

Contacts

Public ContactRui Zhao

The First Affiliated Hospital of Chongqing Medical University

zhaorui9803@163.com+86 155 8850 8045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026